Long-Term Tolerance and Efficacy of Siltuximab (Anti-IL-6) in a Young Adult with Idiopathic Multicentric Castleman Disease During COVID-19
在新冠肺炎期间,Siltuximab(抗IL-6)对一名患有特发性多中心Castleman病的青年患者的长期耐受性和疗效
期刊:European Journal of Case Reports in Internal Medicine
影响因子:
doi:10.12890/2023_004098
Bedier, Helbies; Isnard, Stéphane; Maedler-Kron, Chelsea; Routy, Jean-Pierre